May 10 (SeeNews) - Slovenian blue-chip drug maker Krka [LJE:KRKG] said on Thursday its consolidated net profit edged up to 48.6 million euro ($62.9 million) in the first quarter of 2012 from 47.9 million euro a year earlier.